Experience Avenida Corrientes from a unique aerial and 3D virtual perspective, revealing one of Buenos Aires’ most iconic and ...

Inside Housing’s news team talks to experts from across the housing sector to find out what they are looking forward to – and ...

Karthik Ramgopal and Daniel Hewlett discuss the evolution of AI at LinkedIn, from simple prompt chains to a sophisticated ...

Get the latest Bigbloc Construction share price today on NSE & BSE. Explore Bigbloc Construction stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

Cytokinetics should hear back from the FDA next September about its marketing application for aficamten, which is vying to become the first rival to Bristol-Myers Squibb's fast-growing Camzyos for ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

December 31, 2025 • A few years back, many politicians were raising the alarm about the dangers of "CRT" in schools. Today, the new risk to public education is "DEI." What do both of these moments ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Thomas J Catalano is a CFP and Registered Investment Adviser with the state of ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...